Literature DB >> 17848162

Toll-like receptors and immune regulation: their direct and indirect modulation on regulatory CD4+ CD25+ T cells.

Guangwei Liu1, Yong Zhao.   

Abstract

Regulatory CD4(+) CD25(+) T (Treg) cells with the ability to suppress host immune responses against self- or non-self antigens play important roles in the processes of autoimmunity, transplant rejection, infectious diseases and cancers. The proper regulation of CD4(+) CD25(+) Treg cells is thus critical for optimal immune responses. Toll-like receptor (TLR)-mediated recognition of specific structures of invading pathogens initiates innate as well as adaptive immune responses via antigen-presenting cells (APCs). Interestingly, new evidence suggests that TLR signalling may directly or indirectly regulate the immunosuppressive function of CD4(+) CD25(+) Treg cells in immune responses. TLR signalling may shift the balance between CD4(+) T-helper cells and Treg cells, and subsequently influence the outcome of the immune response. This immunomodulation pathway may therefore have potential applications in the treatment of graft rejection, autoimmune diseases, infection diseases and cancers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17848162      PMCID: PMC2266004          DOI: 10.1111/j.1365-2567.2007.02651.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  79 in total

1.  Immunology. Regulating the regulators.

Authors:  Fiona Powrie; Kevin J Maloy
Journal:  Science       Date:  2003-02-14       Impact factor: 47.728

Review 2.  Regulatory T cells under scrutiny.

Authors:  Jean-François Bach; Jean François Bach
Journal:  Nat Rev Immunol       Date:  2003-03       Impact factor: 53.106

Review 3.  Toll-like receptors: balancing host resistance with immune tolerance.

Authors:  Chandrashekhar Pasare; Ruslan Medzhitov
Journal:  Curr Opin Immunol       Date:  2003-12       Impact factor: 7.486

4.  Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells.

Authors:  Chandrashekhar Pasare; Ruslan Medzhitov
Journal:  Science       Date:  2003-01-16       Impact factor: 47.728

5.  Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology.

Authors:  Sarah C Higgins; Ed C Lavelle; Chantelle McCann; Brian Keogh; Edel McNeela; Patricia Byrne; Brian O'Gorman; Andrew Jarnicki; Peter McGuirk; Kingston H G Mills
Journal:  J Immunol       Date:  2003-09-15       Impact factor: 5.422

6.  Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8.

Authors:  Florian Heil; Hiroaki Hemmi; Hubertus Hochrein; Franziska Ampenberger; Carsten Kirschning; Shizuo Akira; Grayson Lipford; Hermann Wagner; Stefan Bauer
Journal:  Science       Date:  2004-02-19       Impact factor: 47.728

7.  IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway.

Authors:  Katherine A Fitzgerald; Sarah M McWhirter; Kerrie L Faia; Daniel C Rowe; Eicke Latz; Douglas T Golenbock; Anthony J Coyle; Sha-Mei Liao; Tom Maniatis
Journal:  Nat Immunol       Date:  2003-05       Impact factor: 25.606

8.  Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide.

Authors:  Iris Caramalho; Thiago Lopes-Carvalho; Dominique Ostler; Santiago Zelenay; Matthias Haury; Jocelyne Demengeot
Journal:  J Exp Med       Date:  2003-02-17       Impact factor: 14.307

9.  TLR2 is expressed on activated T cells as a costimulatory receptor.

Authors:  Mousa Komai-Koma; Louise Jones; Graham S Ogg; Damo Xu; Foo Y Liew
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-23       Impact factor: 11.205

10.  LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF.

Authors:  Katherine A Fitzgerald; Daniel C Rowe; Betsy J Barnes; Daniel R Caffrey; Alberto Visintin; Eicke Latz; Brian Monks; Paula M Pitha; Douglas T Golenbock
Journal:  J Exp Med       Date:  2003-09-29       Impact factor: 14.307

View more
  56 in total

1.  Engagement of TLR2 reverses the suppressor function of conjunctiva CD4+CD25+ regulatory T cells and promotes herpes simplex virus epitope-specific CD4+CD25- effector T cell responses.

Authors:  Gargi Dasgupta; Aziz Alami Chentoufi; Sylvaine You; Payam Falatoonzadeh; Lourie Ann A Urbano; Ayesha Akhtarmalik; Kimberly Nguyen; Lilit Ablabutyan; Anthony B Nesburn; Lbachir BenMohamed
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-17       Impact factor: 4.799

2.  Toll-like receptor 3-mediated suppression of TRAMP prostate cancer shows the critical role of type I interferons in tumor immune surveillance.

Authors:  Arnold I Chin; Andrea K Miyahira; Anthony Covarrubias; Juli Teague; Beichu Guo; Paul W Dempsey; Genhong Cheng
Journal:  Cancer Res       Date:  2010-03-16       Impact factor: 12.701

3.  Enhanced renewal of regulatory T cells in relation to CD4(+) conventional T lymphocytes in the peripheral compartment.

Authors:  Jeane de Souza Nogueira; Fábio Barrozo do Canto; Caroline Fraga Cabral Gomes Nunes; Pedro Henrique Oliveira Vianna; Luciana de Souza Paiva; Alberto Nóbrega; Maria Bellio; Rita Fucs
Journal:  Immunology       Date:  2015-12-17       Impact factor: 7.397

Review 4.  Mechanisms of regulatory T-cell suppression - a diverse arsenal for a moving target.

Authors:  Dorothy K Sojka; Yu-Hui Huang; Deborah J Fowell
Journal:  Immunology       Date:  2008-03-14       Impact factor: 7.397

Review 5.  Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation.

Authors:  Xiaolun Huang; Daniel J Moore; Robert J Ketchum; Craig S Nunemaker; Boris Kovatchev; Anthony L McCall; Kenneth L Brayman
Journal:  Endocr Rev       Date:  2008-07-29       Impact factor: 19.871

6.  A novel role for proteomics in the discovery of cell-surface markers on stem cells: Scratching the surface.

Authors:  Rebekah L Gundry; Kenneth R Boheler; Jennifer E Van Eyk; Bernd Wollscheid
Journal:  Proteomics Clin Appl       Date:  2008-06-12       Impact factor: 3.494

Review 7.  Modulation of immune responses through direct activation of Toll-like receptors to T cells.

Authors:  G Liu; L Zhang; Y Zhao
Journal:  Clin Exp Immunol       Date:  2010-01-29       Impact factor: 4.330

Review 8.  Graft rejection - endogenous or allogeneic?

Authors:  William R Critchley; James E Fildes
Journal:  Immunology       Date:  2012-06       Impact factor: 7.397

Review 9.  Roles for TNF-receptor associated factor 3 (TRAF3) in lymphocyte functions.

Authors:  Zuoan Yi; Wai Wai Lin; Laura L Stunz; Gail A Bishop
Journal:  Cytokine Growth Factor Rev       Date:  2013-12-25       Impact factor: 7.638

10.  rFliC prolongs allograft survival in association with the activation of recipient Tregs in a TLR5-dependent manner.

Authors:  Jing Hao; Chao Zhang; Ting Liang; Jing Song; Guihua Hou
Journal:  Cell Mol Immunol       Date:  2013-10-07       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.